Newly engineered peptide shows potential as long-acting anti-HIV drug

A newly engineered peptide called IBP-CP24 has the potential to be further developed as a long-acting anti-HIV drug that can be used alone or in combination with a broad neutralizing antibody for the treatment and prevention of HIV-1 infection, according to a new study.

from Top Health News -- ScienceDaily https://ift.tt/2Rys9Rn